- Home
- JHI vs LNSR Comparison
JHI vs LNSR Comparison
Compare JHI & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JHI | LNSR |
|---|---|---|
| Founded | 1971 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 142.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JHI | LNSR |
|---|---|---|
| Price | $13.68 | $12.01 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 29.5K | ★ 47.5K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | N/A | ★ $59,141,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | $12.47 | ★ N/A |
| Revenue Growth | N/A | ★ 21.02 |
| 52 Week Low | $11.63 | $7.25 |
| 52 Week High | $13.40 | $17.31 |
Technical Indicators
Market Signals| Indicator | JHI | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 64.29 |
| Support Level | $13.42 | $11.77 |
| Resistance Level | $13.65 | $11.63 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 26.59 | 85.83 |
Price Performance
Historical ComparisonAbout JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.